schliessen

Filtern

 

Bibliotheken

3.

FOLFOX4 or sorafenib as the first-line treatments for advanced hepatocellular carcinoma: A cost-effectiveness analysis.
by Zhang, Pengfei

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, December 2016, Vol.48(12), pp.1492-1497

1

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 6 Hits

Remove Filters